Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ameres, S.L., Zamore, P.D., 2013. Diversifying microRNA sequence and function. Nat. Rev. Mol. Cell Biol., 14(8):475–488. http://dx.doi.org/10.1038/nrm3611
Baron, V.T., Pio, R., Jia, Z., et al., 2015. Early growth response 3 regulates genes of inflammation and directly activates IL6 and IL8 expression in prostate cancer. Br. J. Cancer, 112(4):755–764. http://dx.doi.org/10.1038/bjc.2014.622
Bartel, D.P., 2009. MicroRNAs: target recognition and regulatory functions. Cell, 136(2):215–233. http://dx.doi.org/10.1016/j.cell.2009.01.002
Bronte, F., Bronte, G., Fanale, D., et al., 2015. Hepatomirnoma:the proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma. Crit. Rev. Oncol. Hematol., 97:312–321. http://dx.doi.org/10.1016/j.critrevonc.2015.09.007
Fang, F., Shangguan, A.J., Kelly, K., et al., 2013. Early growth response 3 (Egr-3) is induced by transforming growth factor-β and regulates fibrogenic responses. Am. J. Pathol., 183(4):1197–1208. http://dx.doi.org/10.1016/j.ajpath.2013.06.016
Farazi, T.A., Juranek, S.A., Tuschl, T., 2008. The growing catalog of small RNAs and their association with distinct Argonaute/Piwi family members. Development, 135(7):1201–1214. http://dx.doi.org/10.1242/dev.005629
Felekkis, K., Touvana, E., Stefanou, C., et al., 2010. MicroRNAs: a newly described class of encoded molecules that play a role in health and disease. Hippokratia, 14(4):236–240.
Fong, Z.V., Tanabe, K.K., 2014. The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: a comprehensive and evidence-based comparison and review. Cancer, 120(18):2824–2838. http://dx.doi.org/10.1002/cncr.28730
Gomez-Martin, D., Diaz-Zamudio, M., Galindo-Campos, M., et al., 2010. Early growth response transcription factors and the modulation of immune response: implications towards autoimmunity. Autoimmun. Rev., 9(6):454–458. http://dx.doi.org/10.1016/j.autrev.2009.12.006
Hu, X., Schwarz, J.K., Lewis, J.S., et al., 2010. A microRNA expression signature for cervical cancer prognosi, Cancer Res., 70(4):1441–1448. http://dx.doi.org/10.1158/0008-5472.can-09-3289
Kimhofer, T., Fye, H., Taylor-Robinson, S., et al., 2015. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br. J. Cancer, 112(7):1141–1156. http://dx.doi.org/10.1038/bjc.2015.38
Leng, R., Zha, L., Tang, L., 2014. MiR-718 represses VEGF and inhibits ovarian cancer cell progression. FEBS Lett., 588(12):2078–2086. http://dx.doi.org/10.1016/j.febslet.2014.04.040
Li, L., Yun, S.H., Keblesh, J., et al., 2007. Egr3, a synaptic activity regulated transcription factor that is essential for learning and memory. Mol. Cell. Neurosci., 35(1):76–88. http://dx.doi.org/10.1016/j.mcn.2007.02.004
Liao, F., Ji, M.Y., Shen, L., et al., 2013. Decreased Egr3 expression is related to poor prognosis in patients with gastric cancer. J. Mol. Histol., 44(4):463–468. http://dx.doi.org/10.1007/s10735-013-9493-8
Lin, M., Chen, W., Huang, J., et al., 2011. MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol. Rep., 25(3):739–747. http://dx.doi.org/10.3892/or.2010.1112
Perez-Cadahia, B., Drobic, B., Davie, J.R., 2011. Activation and function of immediate-early genes in the nervous system. Biochem. Cell Biol., 89(1):61–73. http://dx.doi.org/10.1139/o10-138
Pio, R., Jia, Z., Baron, V.T., et al., 2013. Early growth response 3 (Egr3) is highly over-expressed in nonrelapsing prostate cancer but not in relapsing prostate cancer. PLoS ONE, 8(1):e54096. http://dx.doi.org/10.1371/journal.pone.0054096
Shukla, G.C., Singh, J., Barik, S., 2011. MicroRNAs: processing, maturation, target recognition and regulatory functions. Mol. Cell. Pharmacol., 3(3):83–92.
Singh, R., Yadav, V., Kumar, S., et al., 2015. MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1. Sci. Rep., 5:17454. http://dx.doi.org/10.1038/srep17454
Sugimachi, K., Matsumura, T., Hirata, H., et al., 2015. Identification of a bona fide microRNA biomarker in serum exosomes that predicts hepatocellular carcinoma recurrence after liver transplantation. Br. J. Cancer, 112(3):532–538. http://dx.doi.org/10.1038/bjc.2014.621
Suzuki, T., Inoue, A., Miki, Y., et al., 2007. Early growth responsive gene 3 in human breast carcinoma: a regulator of estrogen-meditated invasion and a potent prognostic factor. Endocr. Relat. Cancer, 14(2):279–292. http://dx.doi.org/10.1677/erc-06-0005
Waller, L.P., Deshpande, V., Pyrsopoulos, N., 2015. Hepatocellular carcinoma: a comprehensive review. World J. Hepatol., 7(26):2648–2663. http://dx.doi.org/10.4254/wjh.v7.i26.2648